Enertork Ltd. (KOSDAQ:019990)
South Korea · Delayed Price · Currency is KRW 9,300.00
-410.00 (-4.22%)
At close: Feb 26, 2026
Enertork Revenue
Enertork had revenue of 4.69B KRW in the quarter ending September 30, 2025, a decrease of -10.79%. This brings the company's revenue in the last twelve months to 23.47B, down -3.82% year-over-year. In the year 2024, Enertork had annual revenue of 25.16B, down -6.62%.
Revenue (ttm)
23.47B
Revenue Growth
-3.82%
P/S Ratio
3.74
Revenue / Employee
279.38M
Employees
84
Market Cap
87.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.16B | -1.78B | -6.62% |
| Dec 31, 2023 | 26.94B | 656.84M | 2.50% |
| Dec 31, 2022 | 26.29B | 3.71B | 16.45% |
| Dec 31, 2021 | 22.57B | -370.77M | -1.62% |
| Dec 31, 2020 | 22.94B | -538.50M | -2.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Creas F&C Co.,Ltd | 484.33B |
| WiTS Co., Ltd. | 143.66B |
| Enzychem Lifesciences | 72.17B |
| Polaris AI Pharma | 63.94B |
| Incross | 50.62B |
| RF Systems | 36.01B |
| Daesung Private Equity | 9.94B |
| CreoSG | 9.69B |